ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Revolutionizing Pediatric Growth Hormone Deficiency Treatment
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 270514" data-attributes="member: 13851"><p>[MEDIA=youtube]aIRnuodjQV0[/MEDIA]</p><p></p><p><strong><em>Rick Hawkins, CEO and chairman of Lumos Pharma, discusses the company’s late-stage development of a small molecule for the treatment of pediatric growth hormone deficiency (PGHD). This innovative oral mini tablet aims to revolutionize the current standard of care, which involves daily injections for several years. The potential impact on the $5 billion global growth hormone market could be significant if the trial results are positive.</em></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Highlights:</strong></p><p></p><ul> <li data-xf-list-type="ul"><em><em>Rick Hawkins, CEO and chairman of Lumos Pharma, discusses the company’s late-stage development of a small molecule for PGHD. </em></em></li> <li data-xf-list-type="ul"><em><em>The global phase 2B trial results for the oral mini tablet in the treatment of PGHD are forthcoming. </em></em></li> <li data-xf-list-type="ul"><em><em>The current standard of care for PGHD involves daily injections for several years. </em></em></li> <li data-xf-list-type="ul"><em><em>The growth hormone market is valued at approximately $5 billion globally. </em></em></li> <li data-xf-list-type="ul"><em><em>Injectable growth hormone is the current standard treatment for PGHD and other growth hormone disorders. </em></em></li> <li data-xf-list-type="ul"><em><em>Lumos Pharma’s innovation aims to provide a daily oral mini tablet as an alternative to daily injections for PGHD patients. </em></em></li> </ul></blockquote><p></p>
[QUOTE="madman, post: 270514, member: 13851"] [MEDIA=youtube]aIRnuodjQV0[/MEDIA] [B][I]Rick Hawkins, CEO and chairman of Lumos Pharma, discusses the company’s late-stage development of a small molecule for the treatment of pediatric growth hormone deficiency (PGHD). This innovative oral mini tablet aims to revolutionize the current standard of care, which involves daily injections for several years. The potential impact on the $5 billion global growth hormone market could be significant if the trial results are positive.[/I] Highlights:[/B] [LIST] [*][I][I]Rick Hawkins, CEO and chairman of Lumos Pharma, discusses the company’s late-stage development of a small molecule for PGHD. [/I][/I] [*][I][I]The global phase 2B trial results for the oral mini tablet in the treatment of PGHD are forthcoming. [/I][/I] [*][I][I]The current standard of care for PGHD involves daily injections for several years. [/I][/I] [*][I][I]The growth hormone market is valued at approximately $5 billion globally. [/I][/I] [*][I][I]Injectable growth hormone is the current standard treatment for PGHD and other growth hormone disorders. [/I][/I] [*][I][I]Lumos Pharma’s innovation aims to provide a daily oral mini tablet as an alternative to daily injections for PGHD patients. [/I][/I] [/LIST] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Revolutionizing Pediatric Growth Hormone Deficiency Treatment
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top